Vicriviroc maleate - paediatric investigation plan

Vicriviroc maleate

Key facts

• Active Substance:
  Vicriviroc maleate
• Therapeutic area:
  Infectious diseases
• Decision number:
  P/188/2009
• PIP number:
  Vicriviroc maleate
• Pharmaceutical form(s):
  Tablet
• Condition(s) / indication(s):
  Treatment of human immunodeficiency virus (HIV-1) infection
• Route(s) of administration:
  Oral use
• Contact for public enquiries:

  Schering-Plough Europe

  E-mail: [e-mail]; Country: Netherlands; Phone: [phone]; Fax: [phone]

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  11/09/2009

Decision

P/188/2009: European Medicines Agency decision of 11 September 2009 on the acceptance of a modification of an agreed Paediatric Investigation Plan for vicriviroc maleate (EMEA-000122-PIP01-07-M01) in accordance with Regu...

AdoptedReference Number: EMEA/525373/2009